The placebo effect in animals

Journal of the American Veterinary Medical Association

Volumn 215, Issue 7, 1999, Pages 992-999

  McMillan, Franklin D ^a  

^a Robertson Blvd Animal Hospital VCA ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; CYCLOPHOSPHAMIDE; NALOXONE; OPIATE; PLACEBO; SACCHARIN; VACCINE;

ANIMAL EXPERIMENT; CONDITIONING; DOG; DRUG EFFECT; DRUG MECHANISM; GUINEA PIG; HEALTH; MOUSE; NONHUMAN; REVIEW; VETERINARY MEDICINE;

ANIMAL POPULATION GROUPS; ANIMALS; BONDING, HUMAN-PET; COGNITION; CONDITIONING (PSYCHOLOGY); OPIOID PEPTIDES; PLACEBO EFFECT;

ANIMALIA; CANIS FAMILIARIS; CAVIA PORCELLUS; SUS SCROFA;

EID: 0033215559     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (76)

1. Bienenfeld L, Frishman W, Glasser SP. The placebo effect in cardiovascular disease. Am Heart J 1996;132:1207-1221.
2. Beecher HK. The powerful placebo. JAMA 1955;159: 1602-1606.
3. Chaput de Saintonge DM, Herxheimer A. Harnessing placebo effects in health care. Lancet 1994; 344:995-998.
4. Peck C, Grahame C. Implications of placebo theory for clinical research and practice in pain management. Theor Med 1991;12:247-270.
5. Shapiro AK, Shapiro E. The powerful placebo: from ancient priest to modern physician. Baltimore: Johns Hopkins University Press, 1997;28-42,228-237.
6. Straus JL, Cavanaugh SVA. Placebo effects: issues for clinical practice in psychiatry and medicine. Psychosomatics 1996; 37:315-326.
7. Lewis CT. A latin dictionary. Oxford, UK: Clarendon Press, 1953;127.
8. Pepper OHP. A note on the placebo. Am J Pharmacy 1945; 117:409-412.
9. Benson H, Epstein MD. The placebo effect. JAMA 1975; 232:1225-1227.
10. Shapiro AK. The placebo effect. In: Clark WG, Del Guidice J, eds. Principles of psychopharmacology. New York: Academic Press Inc, 1978;79-102.
11. Sartorius N. Foreword. In: White L, Tursky B, Schwartz GE, eds. Placebo: theory, research and mechanisms. New York: The Guilford Press, 1985;vii-viii.
12. Voudouris NJ, Peck CL, Coleman G. Conditioned placebo responses. J Pers Soc Psychol 1985;48:47-53.
13. McMillan FD. Influence of mental states on somatic health in animals. J Am Vet Med Assoc 1999;214:1221-1225.
14. Gliedman LH, Gantt WH, Teitelbaum HA. Some implications of conditional reflex studies for placebo research. Am J Psychiatry 1957;113:1103-1107.
15. Ullman LP, Krasner F. Cognitions and behavior therapy. Behav Ther 1969;1:202-204.
16. Herrnstein RJ. Placebo effect in the rat. Science 1962;138: 677-678.
17. Pavlov IP. Conditioned reflexes. London: Oxford Press, 1927;23-78.
18. Pihl RO, Altman MA. An experimental analysis of the placebo effect. J Pharmacol New Drugs 1971;11:91-95.
19. Wikler A, Pescor FT, Miller D, et al. Persistent potency of a secondary (conditioned) reinforcer following withdrawal of morphine from physically dependent rats. Psychophormacologia 1971;20:103-117.
20. Metalnikov S, Chorine V The role of conditioned reflexes in immunity. Ann Pasteur Inst 1926;40:893-900.
21. Siegel S. Conditioning insulin effects. J Compar Physiol Psychol 1975;89:189-199.
22. Hecht T, Baumann R, Hecht K. The somatic and vegetative-regulatory behavior of the healthy organism during conditioning of the insulin effect. Conditional Reflex 1967;2:96-112.
23. Solomon GS, Kay N, Morley JE. Endorphins: a link between personality, stress, emotions, immunity, and disease? In: Plotnikoff NP, Faith RE, Murgo AJ, et al, eds. Enkephalins and endorphins: stress and the immune system. New York: Plenum Press, 1986;129-137.
24. Pert CB. In: Molecules of emotion. New York: Scribner, 1997;190.
25. Russell M, Dark KA, Cummins RW, et al. Learned histamine release. Science 1984;225:733-734.
26. Ader R, Cohen N. Behaviorally conditioned immunosuppression. Psychosom Med 1975;37:333-340.
27. Ader R, Cohen N. Behaviorally conditioned immunosuppression and murine systemic lupus erythematosus. Science 1982; 215:1534-1536.
28. Wikler A, Martin WR, Pescor FT, et al. Factors regulating oral consumption of an opioid (etonitazene) by morphine-addicted rats. Psychopharmacologia 1963;5:55-76.
29. Goldberg SR, Schuster CR. Conditioned suppression by a stimulus associated with nalorphine in morphine-dependent monkeys. J Exp Anal Behav 1967;10:235-242.
30. Roffman M, Reddy C, Lal H. Narcotic withdrawal. In: Singh J, Miller L, Lal H, eds. Drug addiction. New York: Future Publishing, 1972;223.
31. Schuster CR, Woods JH. The conditioned reinforcing effects of stimuli associated with morphine reinforcement. Int J Addict 1968; 3:223-230.
32. Voudouris NJ, Peck CL, Coleman G. The role of conditioning and verbal expectancy in the placebo response. Pain 1990;43:121-128.
33. Voudouris NJ, Peck CL, Coleman G. Conditioned response models of placebo phenomena: further support. Pain 1989;38:109-16.
34. Wickramasekera I. A conditioned response model of the placebo effect: predictions from the model. Biofeedback Self Regul 1980;5:5-18.
35. Plotkin WB. A psychological approach to placebo; the role of faith in therapy and treatment. In: White L, Tursky B, Schwartz GE, eds. Placebo: theory, research and mechanisms. New York: The Guilford Press, 1985;237-254.
36. Bootzin RR. The role of expectancy in behavior change. In: White L, Tursky B, Schwartz GE, eds. Placebo: theory, research and mechanisms. New York: The Guilford Press, 1985;96-210.
37. Evans FJ. Expectancy, therapeutic instructions, and the placebo response. In: White L, Tursky B, Schwartz GE, eds. Placebo: theory, research and mechanisms. New York: The Guilford Press, 1985;15-228.
38. Ross M, Olson JM. An expectancy-attribution model of the effects of placebos. Psychol Rev 1981;88:408-437.
39. Seligman ME. Helplessness: on depression, development, and death. San Francisco: W. H. Freeman & Co, 1975;21-44:166-188.
40. Weiss JM. Psychological factors in stress and disease. Sci Am 1972;226:104-113.
41. Bohus B, Koolhaas JM. Psychoimmunology of social factors in rodents and other subprimate vertebrates. In: Ader R, Felton DL, Cohen N, eds. Psychoneuroimmunology. 2nd ed. New York: Academic Press Inc, 1991;807-830.
42. Laudenslager ML, Ryan SM, Drugan RC, et al. Coping and immunosuppression: inescapable but not escapable shock suppresses lymphocyte proliferation. Science 1983;221:568-570.
43. Sklar LA, Anisman H. Stress and coping factors influence tumor growth. Science 1979;205:513-515.
44. Visintainer MA, Volpicelli JR, Seligman MEP Tumor rejection in rats after inescapable or escapable shock. Science 1982;216:437-439.
45. Izard CE. Human emotions. New York: Plenum Press, 1977;204.
46. Allen C, Bekoff MA. Species of mind: the philosophy and biology of cognitive ethology. Cambridge, Mass: The MIT Press, 1997;61-85.
47. Marks SL. Demystifying the anorectic cat, in Proceedings. 16th Am Coll Vet Int Med Forum 1998;62-63.
48. Levine JD, Gordon NC, Fields HL. The mechanism of placebo analgesia. Lancet 1978;3:654-657.
49. Graceley RH, Dubner R, Wolskee PJ, et al. Naloxone and placebo can alter post surgical pain by separate mechanisms. Nature 1982;306:262-265.
50. Grevert P, Albert LH, Goldstein A. Partial antagonism of placebo analgesia by naloxone. Pain 1983;16:129-143.
51. Posner J, Burke CA. The effects of naloxone on opiate and placebo analgesia in healthy volunteers. Psychopharmacology (Berl) 1985;87:468-472.
52. Pert CB, Ruff MR, Weber RJ, et al. Neuropeptides and their receptors: a psychosomatic network. J Immunol 1985;135:820-826.
53. Gantt WH, Newton JEO, Royer FL, et al. Effect of person. Conditional Reflex 1966;1:18-35.
54. Lynch JJ. Heart rate changes in the horse to human contact. Psychophysiology 1974;11:472-478.
55. Newton JE, Ehrlich WW. Coronary blood flow in dogs: effect of person. Conditional Reflex 1966;1:81.
56. Anderson SL, Gantt WH. The effect of person on cardiac and motor responsivity to shock in dogs. Conditional Reflex 1966;1:181-189.
57. Gross WB. The benefits of tender loving care. Int J Stud Anim Prob 1980;1:147-149.
58. Hemsworth PH, Brand A, Willems PJ. The behavioral response of sows to the presence of human beings and their productivity. Livestock Prod Sci 1981;8:67-74.
59. Hammett FS. Studies of the thyroid apparatus. Am J Physiol 1921;56:196-204.
60. Nerem RM, Levesque MJ, Cornhill JF. Social environment as a factor in diet-induced atherosclerosis. Science 1980;208: 1475-1476.
61. Riley V, Fitzmaurice MA, Spackman DH. Psychoneuroimmunologic factors in neoplasia: studies in animals. In: Ader R, ed. Psychoneuroimmunology. New York: Academic Press Inc, 1981;31-102.
62. Riley V. Psychoneuroendocrine influences on immunocompetence and neoplasia. Science 1981;212:1100-1109.
63. Henry JP. The induction of acute and chronic cardiovascular disease in animals by psychosocial stimulation. Int J Psychiatry Med 1975;6:147-158.
64. Solomon GF, Moos RH. Emotions, immunity, and disease. Arch Gen Psychiatry 1964;11:657-674.
65. Shavit Y, Terman GW, Martin FC, et al. Stress, opioid peptides, the immune system, and cancer. J Immunol 1985;135:834-837.
66. Keller SE, Schleifer SJ, Demetrikopoulos MK. Stress-induced changes in immune function in animals: hypothalamo-pituitary-adrenal influences. In: Ader R, Felton DL, Cohen N, eds. Psychoneuroimmunology. 2nd ed. New York: Academic Press Inc, 1991;771-787.
67. Shavit Y. Stress-induced immune modulation in animals: opiates and endogenous opioid peptides. In: Ader R, Felton DL, Cohen N, eds. Psychoneuroimmunology. 2nd ed. New York: Academic Press Inc, 1991;789-806.
68. Brown WA. The placebo effect. Sci Am 1998;278:90-95.
69. Laudenslager ML, Boccia ML. Some observations on psychosocial Stressors, immunity, and individual differences in nonhuman primates. Am J Primatol 1996;39:205-221.
70. Coe CL. Psychosocial factors and immunity in nonhuman primates: a review. Psychosom Med 1993;55:298-308.
71. Straw RC, Rodney C. Why treat cancer in pets?, in Proceedings. Oregon Vet Med Assoc Summer Meet 1996;8-9.
72. Fedderson-Peterson D. Some interactive aspects between dogs and their owners: are there reciprocal influences between both inter- and intraspecific communication? Appl Anim Behav 1994; 40:78-84.
73. Vasseur PB, Johnson AL, Budsberg SC, et al. Randomized, controlled trial of the efficacy of carprofen, a nonsteroidal antiinflammatory drug, in the treatment of osteoarthritis in dogs. J Am Vet Med Assoc 1995;206:807-811.
74. Oh VMS. The placebo effect: can we use it better? Br Med J 1994;309:69-70.
75. Buckman R, Lewith G. What does homeopathy do - and how? Br Med J 1994;309:103-106.
76. Kienle GS, Kiene H. The powerful placebo effect: fact or fiction? J Clin Epidemiol 1997;50:1311-1318.